Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects

Rusconi, S; Saladini, F; Bellocchi, MC; Galli, L; Gagliardini, R; Gazzola, L; Francisci, D; Vichi, F; Foca, E; Zazzi, M; Santoro, MM; Gabrieli, A; Castagna, A

Rusconi, S (通讯作者)，Univ Milan, Infect Dis Unit, ASST Ovest Milanese, Legnano Gen Hosp,DIBIC Luigi Sacco, Milan, Italy.

PHARMACOLOGICAL RESEARCH, 2022; 176 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索